Julien Broséus

Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

Julien Broséus, Tamara Alpermann, Michael Wulfert et al. · Leukemia · 2013 · 98 citations · Full text

Hematological Malignancy, Refractory Anaemia, Bone Marrow Failure +7

Presence of calreticulin mutations in JAK2-negative polycythemia vera

Julien Broséus, Ji‐Hye Park, Serge Carillo et al. · Blood · 2014 · 94 citations · Full text

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

Julien Broséus, Lourdes Florensa, E. Zipperer et al. · Haematologica · 2012 · 90 citations · Full text

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry, Ignaty Leshchiner, Romain Guièze et al. · Nature Medicine · 2023 · 79 citations · Full text

Hematological Malignancy, Chronic Lymphocytic Leukemia, Evolutionary History +8

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Erin M. Parry, Camilla K. Lemvigh, Stephanie Deng et al. · Cancer Cell · 2023 · 70 citations · Full text

Hematological Malignancy, Autoimmune Disease, Anti-pd-1 Therapy +9